Urotensin-II promotes vascular smooth muscle cell proliferation through store-operated calcium entry and EGFR transactivation.
about
STIM and Orai1 Variants in Store-Operated Calcium EntryTransactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future ResearchUrotensin II promotes atherosclerosis in cholesterol-fed rabbits.Urotensin-ⅡReceptor Antagonist SB-710411 Protects Rat Heart against Ischemia-Reperfusion Injury via RhoA/ROCK Pathway.Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits.Orai channel-mediated Ca2+ signals in vascular and airway smooth muscle.Blockade of Urotensin II Receptor Prevents Vascular Dysfunction.Urotensin II promotes vagal-mediated bradycardia by activating cardiac-projecting parasympathetic neurons of nucleus ambiguus.Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy.Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.Vascular CaMKII: heart and brain in your arteries.Orai1 and TRPC1 Proteins Co-localize with CaV1.2 Channels to Form a Signal Complex in Vascular Smooth Muscle Cells.Specific titin and myomesin domains stimulate myoblast proliferation.Urotensin II-induced store-operated Ca2+ entry contributes to glomerular mesangial cell proliferation and extracellular matrix protein production under high glucose conditions.Cardiovascular and Hemostatic Disorders: Role of STIM and Orai Proteins in Vascular Disorders.Introduction: Overview of the Pathophysiological Implications of Store-Operated Calcium Entry in Mammalian Cells.The Complex Role of Store Operated Calcium Entry Pathways and Related Proteins in the Function of Cardiac, Skeletal and Vascular Smooth Muscle Cells.TRPC6 and TRPC4 Heteromultimerization Mediates Store Depletion-Activated NCX1 Reversal in Proliferative Vascular Smooth Muscle Cells.
P2860
Q26770429-36C7B5FA-3D78-4678-8169-9266F36A4C68Q26771727-F49CB996-74FA-47AA-9F9A-5C51EC1D80D2Q35152923-38EFBBA3-6C8C-44EA-B60F-10693348803AQ35895186-1DE5BCE8-CCE8-4716-BBBB-3F594E01B255Q36320177-17E5BF2F-2BAD-429B-82ED-77E2044C7023Q36698766-84E2B4AB-DE30-44C2-90FB-CD9120635B8AQ37235264-9A0911E1-4BF8-4DA3-92AF-08E3C1C7C5CFQ37724223-E9D4BA8F-6FC1-4151-AAE6-438F7B65941BQ38196857-15DD16A6-E6E2-46F4-BC55-304F0B3F4DDBQ38698722-F1FE583A-AF10-4170-B64F-B547029BAD08Q38866040-BD44F0D8-7402-4AA6-B45F-573D296EAFB0Q39480241-BA33C277-4FBE-4FEC-8062-834ACAE47D0DQ41682420-C07B4894-D66C-4702-9266-B541FE098E72Q47111065-02505374-6054-46D6-84CF-C80D63A4CFB3Q47812869-DA630881-F6DF-423E-8578-5E17E2358479Q47812893-7C1FBC6B-417B-474C-95E9-B73CF81AD242Q52331702-650D715B-9270-4E46-B0AA-2C452475E994Q52725298-1311F4E8-4FBA-4319-944D-51AF5A068E98
P2860
Urotensin-II promotes vascular smooth muscle cell proliferation through store-operated calcium entry and EGFR transactivation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Urotensin-II promotes vascular ...... ntry and EGFR transactivation.
@en
type
label
Urotensin-II promotes vascular ...... ntry and EGFR transactivation.
@en
prefLabel
Urotensin-II promotes vascular ...... ntry and EGFR transactivation.
@en
P2093
P2860
P50
P356
P1476
Urotensin-II promotes vascular ...... ntry and EGFR transactivation.
@en
P2093
Ignacio Díaz
María Rodríguez-Moyano
Mohamed Trebak
Natalia Dionisio
Xuexin Zhang
P2860
P304
P356
10.1093/CVR/CVT196
P577
2013-08-09T00:00:00Z